Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

Slight Shift Seen After Calories Added to Fast-food Menus

News Daily News

Slight Shift Seen After Calories Added to Fast-food Menus

December 15, 2023

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

November 22, 2023

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

November 15, 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

November 14, 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

October 27, 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

October 26, 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

October 26, 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

October 25, 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

October 23, 2023

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

September 18, 2023

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

September 14, 2023

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.